-+ 0.00%
-+ 0.00%
-+ 0.00%

Rhelion Subsidiary Filament Health Secures US Patent for Psilocybin Extraction

PUBT·11/19/2026 13:10:22
Listen to the news
Rhelion Subsidiary Filament Health Secures US Patent for Psilocybin Extraction
  • Rhelion Life Sciences' wholly owned subsidiary Filament Health received a new US patent covering psychoactive alkaloid extraction and compositions with inhibited dephosphorylation.
  • The grant expands Filament's portfolio to 79 issued patents across 13 patent families, protecting production methods for its natural psilocybin drug candidate PEX010.
  • PEX010 supports more than 80 academic and philanthropic research studies worldwide.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rhelion Life Sciences Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202611190809NEWSFILECNPR____20261119_324866_1) on November 19, 2026, and is solely responsible for the information contained therein.